Deltex at AAGBI

The Association of Anaesthetists of Great Britain and Ireland holds its annual congress next week in Dublin, details here. As  haemodynamic monitoring technology leader, Deltex will of course be there, exhibiting its TrueVue system. Clinical evidence, notably the FEDORA RCT, published since the last AAGBI annual congress, tells us that monitoring using the oesophageal Doppler (ODM) system significantly reduces haemodynamic complications. This major congress represents another opportunity to reinforce the message that we can help clinicians to deliver better care at lower cost. Deltex’s TrueVue enhanced system now delivers haemodynamic monitoring in all scenarios, now incorporating best-in-class noninvasive solutions on the same platform as its flagship oesophageal Doppler core technology.